Welcome

Liverpool ECMC aims to advance experimental cancer medicine by conducting early phase (phase I/II) clinical trials and performing molecular analysis of patients’ blood and tumour samples.

Research activities have been facilitated by the opening of new laboratories, enabling sample collection, storage, processing, and downstream translational research studies. Studies are conducted on various cancer types.